Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies
Author:
Affiliation:
1. Division of Hematology/Oncology, Department of Medicine, Columbia University Medical Center, New York- Presbyterian Hospital, Herbert Irving Comprehensive Cancer Center, New York, NY, United States
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Radiology Nuclear Medicine and imaging
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeted Alpha Therapy: All We Need to Know about 225Ac’s Physical Characteristics and Production as a Potential Theranostic Radionuclide;Pharmaceuticals;2023-12-02
2. Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review;Pharmaceutics;2023-06-13
3. Preparation and characterization of α-zirconium phosphate as a perspective material for separation of 225Ac and 213Bi;Journal of Radioanalytical and Nuclear Chemistry;2023-01-27
4. Lysine-Directed Site-Selective Bioconjugation for the Creation of Radioimmunoconjugates;Bioconjugate Chemistry;2022-08-10
5. Radiotheranostic Agents in Hematological Malignancies;Frontiers in Immunology;2022-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3